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528a Tuesday, February 23, 2010them. Action potential onset occurred synchronously within the TAT network
of NTG and TG cardiomyocytes. Whereas the repolarization time course was
similar between the three recording sites in NTG or TG hearts (Figure A), over-
all repolarization was prolonged in TG cardiomyocytes (Figure B). Thus, elec-
trical coupling between the surface and TATmembrane was maintained despite
pronounced TATmembrane restructuring in this model of cardiac hypertrophy.
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Interest in non-selective channels has increased recently following the dis-
covery of transient receptor potential (TRP) proteins, which underlie many
of these channels. We used the whole-cell patch-clamp technique on isolated
ventricular myocytes to investigate the effect of fenamates on membrane ion
currents. With voltage-dependent and other ion channels inhibited, all cells
that were challenged with either N-(p-amylcinnamoyl)anthranilic acid
(ACA, R 3mM), ONO-RS-082 (R 100mM) or flufenamic acid (R
100mM) responded with an increase in currents (induced current:
0.850.06 pA/pF at 120 mV with 30 mM ACA; n=9). ACA was the
most potent (K0.5 ¼13 mM) of all drugs tested. The induced current reversed
at þ4352.2 mV (n=9) and its inward but not outward component was sup-
pressed in Naþ-free extracellular conditions (Naþ replaced by NMDGþ). The
current and its reversal potential (Erev) were unaffected by lowering extracel-
lular Cl- concentration or by the removal of extracellular Ca2þ and Mg2þ.
The current could not be induced by other non-fenamate anti-inflammatory
drugs such as diclofenac, nor by non-fenamate phospholipase-A2 inhibitors
such as bromoenol lactone and bromophenacyl bromide. Muscarinic or a-
adrenergic receptor activation or application of diacylglycerol failed to in-
duce or enhance the current. The lack of effect of removing extracellular
divalent cations and the fact that the induced current could be obtained in
the presence of high intracellular Mg2þ indicated that the channel implicated
is not TRPM7. Given our experimental conditions, where Naþ is the only
ion with an equilibrium potential close to the above Erev values, it is very
likely that Naþ carries the novel current induced by fenamates.
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Transgenic mice with cardiac specific overexpression of the human type 1
angiotensin II receptor (AT1R mice) develop hypertrophy and decreased car-
diac contractility. However, it is unclear whether altered contractility is at-
tributable to hypertrophy or AT1R overexpression and whether this differs
between sexes. Since L-type Ca2þ current (ICaL) is crucial for cardiac con-
traction, we characterized the effects of AT1R overexpression on ventricular
ICaL in the presence (older mice: 6-month) or absence (younger mice: 50-
day) of cardiac hypertrophy in both male (M) and female (F) mice. Volt-
age-clamp recordings revealed the density of ICaL did not differ between
sexes for either age group for AT1R and wild-type (WT) mice. However,
ICaL density (in pA/pF) was significantly reduced in ventricular myocytes
from 50-day male and female AT1R mice (at 0 mV, M: 4.250.3, n=17
and F: 3.250.3, n=6) compared to age-matched WT (M: 7.450.4,
n=20 and F: 6.850.9, n=5) (all p<0.05). Similarly, ICaL was significantly
reduced in 6-month male and female AT1R myocytes (at 0 mV, M:
3.650.2, n=15 and F: 3.050.4, n=5) in comparison to WT cells (M:
5.950.2 n=17 and F: 6.450.2 n=10) (all p<0.05). Using real-time RT-
PCR, we showed that ventricular CaV1.2 (L-type Ca
2þ channel a-subunit)
mRNA expression was decreased in 50-day and 6-month male and female
AT1R mice compared to age- and sex-matched WT mice. Overall, the
data indicates that the reduction in ICaL and CaV1.2 in AT1R mice occurs
independently of sex and cardiac remodelling. These alterations could con-
tribute to the decreased cardiac contractility observed in AT1R mice.
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Richmond, VA, USA.We previously demonstrated that bacterial sphingomyelinase (SMase) activates
a volume-sensitive current, ICl,swell, by a pathway that involves mitochondrial
ROS production. SMase activity generates endogenous ceramides from sphin-
gomyelin in the outer plasma membrane leaflet and, in turn, ceramides are me-
tabolized to several sphingolipids, including sphingosine-1-phosphate (S1P).
We tested whether ceramide metabolites are responsible for eliciting ICl,swell.
Under isosmotic conditions that isolate anion currents, SMase-induced ICl,swell
was abrogated by blockade of ceramidase (converts ceramide to sphingosine)
with D-erythro-MAPP (10 mM). SMase-induced ICl,swell also was suppressed
by inhibition of sphingosine kinase with DL-threo-dihydrosphingosine
(10 mM). These data suggested that the ceramide metabolite S1P is likely to
stimulate ICl,swell. As expected, exogenous S1P (500 nM) elicited an outwardly
rectifying Cl- current that was fully inhibited by the ICl,swell-specific blocker
DCPIB (10 mM). As seen with SMase-induced ICl,swell, S1P-induced ICl,swell
was fully inhibited by the mitochondrial Complex I blocker rotenone
(10 mM), which suppresses extramitochondrial ROS release by Complex III.
In contrast to results with SMase, S1P-induced current was partially inhibited
by blockade of NADPH oxidase (NOX) with apocynin (500 mM). These data
indicate that S1P is a necessary component of SMase-induced ICl,swell activa-
tion and that the action of exogenous S1P involves ROS from both mitochon-
dria and NOX. Importantly, exogenous C2-ceramide (2 mM), a synthetic
short-chain ceramide, also elicits ICl,swell even though C2-ceramide is not me-
tabolized to S1P in native cells. Thus, it seems likely that ceramides can elicit
ICl,swell via S1P and also by a distinct pathway and that both pathways converge
at mitochondrial ROS.
2729-Pos
Modeling the Dynamic Currents Recorded under Action Potential-Clamp
in Cardiac Myocytes
Leighton T. Izu1, Tamas Banyasz1,2, Ye Chen-Izu1.
1UC Davis, Davis, CA, USA, 2Univ. of Debrecen, Debrecen, Hungary.
The rhythm and shape of the cardiac action potential (AP) adapt on a moment-
to-moment basis to our physical activity, emotional state, even our breathing.
Underlying this exquisite adaptability is a constellation of ion channels and
transporters that respond to extracellular and intracellular signals and the mem-
brane voltage itself. At any moment, the dynamical behavior of the AP is gov-
erned by the sum of all ionic currents. Subtle changes in the kinetics or magni-
tudes of some currents can upset the precise choreography and generate, for
example, early after-depolarization (EAD), which are often precursors to ec-
topic arrhythmias. Current cardiac AP models can reproduce the steady state
AP properties but is less successful in accurately describing the transient/dy-
namic behavior of the AP such as those during adaptation and restitution, which
are indicators of arrhythmias.
We hypothesized that this inaccuracy could be due to the experimental methods
used to obtain the data for creating models. Current models are largely based on
the experimental data obtained from traditional voltage clamp experiments us-
ing square pulse protocol and non physiological milieu. To overcome this lim-
itation, we used the self AP-clamp technique to record the dynamic ionic cur-
rents under the cell’s own AP in physiological milieu, which provides an
accurate measure of the ionic currents experienced by the cell in situ. Here
we report the modeling results describing the dynamic behavior of the ionic
currents measured during the AP in guinea pig ventricular myocytes.
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Kv channels play important roles in the repolarization phase of the action po-
tential in cardiac cells. The regulation of functional Kv1.5 surface expression
has been reported to be modulated by retrograde trafficking through dynein mo-
tor but little is known about regulation by forward trafficking. Here, we use
electrophysiological and immunocytochemical methods to investigate the
mechanisms and regulation of anterograde trafficking of newly synthesized
Kv1.5 channel proteins in cultured cells and in adult cardiomyocytes. Over-ex-
pression of a kinesin I isoform (Kif5b) increased outward Kþ current by two
fold in cultured cells stably expressing Kv1.5. This enhancement of Kv1.5 cur-
rent by Kif5b was blocked by a six hour treatment with Brefeldin A. Over-ex-
pression of Kif5b increased Kv1.5 current additively with inhibition of endocy-
tosis by p50 over-expression and dynamin inhibitory peptide. Deletion of
a specific SH3-binding domain in Kv1.5 that is essential for internalization
of the channel similarly enhanced Kif5b-induced Kv1.5 current. Expression
of a dominant negative Kif5b mutant prior to induction of Kv1.5 in a tetracy-
cline-inducible system almost completely blocked Kv1.5 current. These results
